Janice Wahl

Janice Wahl

UNVERIFIED PROFILE

Are you Janice Wahl?   Register this Author

Register author
Janice Wahl

Janice Wahl

Publications by authors named "Janice Wahl"

Are you Janice Wahl?   Register this Author

33Publications

1917Reads

18Profile Views

Elbasvir-Grazoprevir to Treat Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy: A Randomized Trial.

Ann Intern Med 2016 Nov 9;165(9):625-634. Epub 2016 Aug 9.

From The Kirby Institute, UNSW Australia, Sydney, Australia; Yale School of Medicine, New Haven, Connecticut; Montefiore Medical Center, Bronx, New York; Akershus University Hospital, Lorenskog, Norway; Auckland Clinical Studies, Auckland, New Zealand; Tel Aviv Sourasky Medical Center, Tel Aviv, Israel; University of California, San Francisco, San Francisco, California; ID Care, Hillsborough, New Jersey; China Medical University, Taichung, Taiwan; Vancouver Infectious Diseases Centre, Vancouver, British Columbia, Canada; and Merck & Co., Kenilworth, New Jersey.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7326/M16-0816DOI Listing
November 2016

Boceprevir plus peginterferon/ribavirin for treatment of chronic hepatitis C in Russia.

World J Hepatol 2016 Feb;8(6):331-9

Vasily Isakov, Department of Gastroenterology and Hepatology, Institute of Nutrition, Moscow 115446, Russia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4254/wjh.v8.i6.331DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4766261PMC
February 2016

Grazoprevir, Elbasvir, and Ribavirin for Chronic Hepatitis C Virus Genotype 1 Infection After Failure of Pegylated Interferon and Ribavirin With an Earlier-Generation Protease Inhibitor: Final 24-Week Results From C-SALVAGE.

Clin Infect Dis 2016 Jan 14;62(1):32-6. Epub 2015 Sep 14.

Liver Unit, Hospital Clinic, Institut d'Investigacions Biomèdiques August Pi i Sunyer and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/cid/civ722DOI Listing
January 2016

Long-term follow-up of patients receiving boceprevir for treatment of chronic hepatitis C.

Antiviral Res 2015 Jan 24;113:71-8. Epub 2014 Oct 24.

Merck Sharp & Dohme Corp., Whitehouse Station, NJ, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.antiviral.2014.10.010DOI Listing
January 2015

Development of boceprevir: a first-in-class direct antiviral treatment for chronic hepatitis C infection.

Ann N Y Acad Sci 2013 Jul;1291:69-76

Merck Research Laboratories, West Point, Pennsylvania 19486, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/nyas.12218DOI Listing
July 2013

Determination of posaconazole levels in toenails of adults with onychomycosis following oral treatment with four regimens of posaconazole for 12 or 24 weeks.

Antimicrob Agents Chemother 2011 Sep 11;55(9):4424-6. Epub 2011 Jul 11.

Merck & Co., Inc., 2015 Galloping Hill Road, Kenilworth, NJ 07033, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/AAC.01302-10DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165322PMC
September 2011